Clinical Trials Browser

Phase 2 × Temozolomide × Other hematologic neoplasm × Clear all

NCT00611247 2018-06-15

Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia

Phase 2 Completed

42 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myeloid

NCT00687323 2017-06-07

TALL

Phase 2 Completed

47 enrolled 12 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute